Decreased appetite is technically the desired effect, but we monitor to ensure youre still getting adequate nutrition
It was unpopular in the industry (again the quiet thing out loud), but it led to a massive commercial success and more patients gaining access
Questions about practical considerations: What is the titration schedule, and how long before I reach the target dose
Why GIP Was Initially Controversial Early studies in people with type 2 diabetes found that their insulin response to GIP was diminished compared to people without diabetes
Tran partners closely with you to assess eligibility, explain benefits and potential side-effects (like nausea or gastrointestinal discomfort), and monitor your progress over time
The oral formulations segment is expected to expand at the fastest CAGR over the projection period, driven by patient preference for non-injectable options